Healthcare -
Biotechnology - NASDAQ - US
$ 1.27
1.6 %
$ 145 M
Market Cap
-0.77
P/E
FATE - LONG-TERM DEBT
Long-term Debt FATE - Fate Therapeutics, Inc.
97.4 M
LAST VALUE
-5.59%
2 YEAR CAGR
50.89%
5 YEAR CAGR
0.00%
10 YEAR CAGR